Shenzhen Bioeasy Biotechnology Co.,Ltd.’s Net Profit Rose 30.3% in First Quarter of 2022

Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net profit of 114.1 million yuan in the first quarter of 2022, up 30.3% year-on-year.

Meanwhile, the company posted 294 million yuan in revenue, up 100.1% year-on-year.

At the end of the reporting period, it had 1.3 billion yuan in total assets and 264.9 million yuan in total liabilities, with a liability-to-asset ratio of 19.8%.